| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein
|
|
AR
|
androgen receptor
|
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like)
|
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like)
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ATF2
|
activating transcription factor 2
|
|
AURKB
|
aurora kinase B
|
|
BAG1
|
BCL2-associated athanogene
|
|
BCR
|
breakpoint cluster region
|
|
BDP1
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
|
|
BNC2
|
basonuclin 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRF1
|
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBX1
|
chromobox homolog 1
|
|
CBX4
|
chromobox homolog 4
|
|
CBX5
|
chromobox homolog 5
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNT2
|
cyclin T2
|
|
CDC27
|
cell division cycle 27
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK14
|
cyclin-dependent kinase 14
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK3
|
cyclin-dependent kinase 3
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CSK
|
c-src tyrosine kinase
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CUX1
|
cut-like homeobox 1
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E4F1
|
E4F transcription factor 1
|
|
EID1
|
EP300 interacting inhibitor of differentiation 1
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain)
|
|
EP300
|
E1A binding protein p300
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GTF3C2
|
general transcription factor IIIC, polypeptide 2, beta 110kDa
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
INS
|
insulin
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
L3MBTL2
|
l(3)mbt-like 2 (Drosophila)
|
|
LIN54
|
lin-54 DREAM MuvB core complex component
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LMNA
|
lamin A/C
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MNAT1
|
MNAT CDK-activating kinase assembly factor 1
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MORF4L1
|
mortality factor 4 like 1
|
|
MORF4L2
|
mortality factor 4 like 2
|
|
MRFAP1
|
Morf4 family associated protein 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOD1
|
myogenic differentiation 1
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PHB
|
prohibitin
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PLK2
|
polo-like kinase 2
|
|
PML
|
promyelocytic leukemia
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
PON2
|
paraoxonase 2
|
|
PPA1
|
pyrophosphatase (inorganic) 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRMT2
|
protein arginine methyltransferase 2
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PURA
|
purine-rich element binding protein A
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
RBAK
|
RB-associated KRAB zinc finger
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RBBP5
|
retinoblastoma binding protein 5
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBBP9
|
retinoblastoma binding protein 9
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RING1
|
ring finger protein 1
|
|
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SEPT4
|
septin 4
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAPC1
|
small nuclear RNA activating complex, polypeptide 1, 43kDa
|
|
SNAPC3
|
small nuclear RNA activating complex, polypeptide 3, 50kDa
|
|
SNW1
|
SNW domain containing 1
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SUV420H2
|
suppressor of variegation 4-20 homolog 2 (Drosophila)
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TBP
|
TATA box binding protein
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFDP1
|
transcription factor Dp-1
|
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2)
|
|
TGM2
|
transglutaminase 2
|
|
THOC1
|
THO complex 1
|
|
TMPO
|
thymopoietin
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP73
|
tumor protein p73
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIP11
|
thyroid hormone receptor interactor 11
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
USP4
|
ubiquitin specific peptidase 4 (proto-oncogene)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VSX2
|
visual system homeobox 2
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|